Folotyn

Product manufactured by Allos Therapeutics

Application Nr Approved Date Route Status External Links
NDA022468 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Folotyn Is Indicated For The Treatment Of Patients With Relapsed Or Refractory Peripheral T-Cell Lymphoma (Ptcl). This Indication Is Based On Overall Response Rate. Clinical Benefit Such As Improvement In Progression-Free Survival Or Overall Survival Has Not Been Demonstrated. Folotyn Is A Folate Analog Metabolic Inhibitor Indicated For The Treatment Of Patients With Relapsed Or Refractory Peripheral T-Cell Lymphoma (Ptcl). This Indication Is Based On Overall Response Rate. Clinical Benefit Such As Improvement In Progression-Free Survival Or Overall Survival Has Not Been Demonstrated. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pralatrexate PRALATREXATE ZINC1536109

Comments